IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, has successfully closed a private placement offering, generating approximately US$4.1 million in gross proceeds. The offering involved the issuance of 2,050,000 units at a price of C$2.7427 per unit. Pure Equity Ltd. acted as a consultant for this transaction. The funds raised are intended for general working capital, repayment of existing debt, and other corporate purposes. The company has committed to filing a resale registration statement to facilitate the resale of shares by investors, with efforts to make it effective as soon as possible.